Sanofi acquires Colombia's second largest generics maker Genfar
This article was originally published in Scrip
Executive Summary
Sanofi has agreed to acquire the Colombian generics company Genfar, which had sales of $133 million last year. The firm is the second largest generic company in terms of sales operating in the country, and the volume leader, Sanofi said. It also has a commercial presence in Venezuela, Peru, Ecuador and 10 other Latin American countries, with 30% of its sales outside Colombia.